Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Markus Guenther"'
Autor:
Markus Günther
Was heißt schon Erwachsenwerden? Wo beginnt es, und wo hört es auf? Und was muss dabei geschehen? Markus Günther hat eine klassische «Coming of Age»-Geschichte geschrieben, und doch fällt sein Held Lutz Brokbals aus jedem literarischen Rahmen.
Many firms resort to scenario analysis as a tool for supporting strategic technology planning. For this purpose, alternative future scenarios are set up and contrasted with potential courses of action that take into account, for instance, new product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba971739e24ae34d1380e9c7c2477b0d
https://pub.uni-bielefeld.de/record/2908092
https://pub.uni-bielefeld.de/record/2908092
Autor:
Christian Gross, Sebastian Meyer, Simon Oechsner, Konstantin Pussep, Markus Guenther, Frank Lehrieder
Publikováno v:
Computer Networks. 56:1118-1130
Peer-to-peer (P2P) based overlays often ignore the boundaries of network domains and make traffic management challenging for network operators. Locality-aware techniques are a promising approach to alleviate this impact, but often benefit only networ
Autor:
Eckhard Thiel, Holger Hebart, Delia Kurzwelly, Michael Weller, Agnieszka Korfel, Ulrich Herrlinger, Juergen Loeffler, Michael Linnebank, Stefan Knop, Markus Guenther, Matthias Simon
Functional genetic polymorphisms involved in folate and methionine metabolism play an important role in both DNA synthesis and methylation, and affect the risk of various malignancies including lymphoproliferative disorders such as systemic non-Hodgk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67062d738bd6bec7a68d3e7066ea515
https://www.zora.uzh.ch/id/eprint/33279/
https://www.zora.uzh.ch/id/eprint/33279/
Autor:
Holger Hebart, Markus Guenther, Ulrich Herrlinger, Michael Weller, Juergen Loeffler, Hermann Einsele, Agnieszka Korfel, Stefan Knop
Publikováno v:
Blood. 108:2580-2580
Background: Outcome of patients with immunocompetent primary central nervous system lymphoma (PCNSL) has improved since the introduction of high-dose (HD) methotrexate (MTX). However, treatment may be perturbed by considerable toxicity. Acute toxicit
Autor:
Holger Hebart, Ulrich Herrlinger, Stefan Knop, Michael Steffens, Markus Guenther, Juergen Loeffler, Agnieszka Korfel, Hermann Einsele, Michael Weller
Publikováno v:
Blood. 106:4439-4439
The antifolate methotrexate (MTX) was shown to be the single most-effective agent in first-line treatment of patients with primary central nervous system lymphoma (PCNSL) when given intravenously in high doses. MTX inhibits 5,10-methylentetrahydrofol